Insider Trading & Ownership - CLARKE JOHN K

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for CLARKE JOHN K
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-05-21
Sale
2021-05-25
9:05 pm
aTYR PHARMA INCLIFECLARKE JOHN K
Director
2,500$4.34$10,850115,575
(Indirect
Direct)
View
2020-08-28
Sale
2020-09-03
9:47 pm
aTYR PHARMA INCLIFECLARKE JOHN K
Director
7,360$4.0099$29,513118,075
(Indirect
Direct)
View
2020-08-26
Sale
2020-08-28
9:09 pm
aTYR PHARMA INCLIFECLARKE JOHN K
Director
7,640$4.1493$31,701125,435
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-22
Option Award
2024-05-23
7:30 pm
N/A
2034-05-22
aTYR PHARMA INCLIFECLARKE JOHN K
Director
24,000$024,000
(Direct)
View
2023-05-17
Option Award
2023-05-19
4:23 pm
N/A
2033-05-17
aTYR PHARMA INCLIFECLARKE JOHN K
Director
12,000$012,000
(Direct)
View
2023-04-26
Exercise
2023-04-28
4:54 pm
N/A
N/A
aTYR PHARMA INCLIFECLARKE JOHN K
Director
6,000$019,797
(Direct)
View
2022-04-26
Option Award
2022-04-28
7:39 pm
N/A
N/A
aTYR PHARMA INCLIFECLARKE JOHN K
Director
6,000$06,000
(Direct)
View
2021-04-28
Option Award
2021-04-29
8:02 pm
N/A
2031-04-28
aTYR PHARMA INCLIFECLARKE JOHN K
Director
1,428$01,428
(Direct)
View
2020-05-06
Option Award
2020-05-08
4:48 pm
N/A
2030-05-06
aTYR PHARMA INCLIFECLARKE JOHN K
Director
1,428$01,428
(Direct)
View